Reata Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Reata Pharmaceuticals, Inc.‘s stocks are currently a part of 137 hedge funds’ portfolios, which represents 70.89% of the total amount of its stocks outstanding. This makes up a total of 25.85M shares of Reata Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -5.97% or -1.64M shares fewer. As for the holding position changes, 27.74% (38) of current hedge fund investors increased the number of shares held, 29.93% (41) of current holders sold a part of the shares held, and 13.14% (18) closed the holdings completely. 30 hedge funds are new holders of Reata Pharmaceuticals, Inc. stock in Q3 2022, it is 21.9% of total holders.
Hedge funds holding Reata Pharmaceuticals (Q4 2017 – Q3 2022)
| Q4 2017 | 89 |
|---|---|
| Q1 2018 | 86 |
| Q2 2018 | 93 |
| Q3 2018 | 119 |
| Q4 2018 | 131 |
| Q1 2019 | 155 |
| Q2 2019 | 155 |
| Q3 2019 | 162 |
| Q4 2019 | 215 |
| Q1 2020 | 212 |
| Q2 2020 | 207 |
| Q3 2020 | 184 |
| Q4 2020 | 198 |
| Q1 2021 | 200 |
| Q2 2021 | 192 |
| Q3 2021 | 178 |
| Q4 2021 | 144 |
| Q1 2022 | 141 |
| Q2 2022 | 136 |
| Q3 2022 | 137 |
Hedge funds changes in Reata Pharmaceuticals positions (Q4 2017 – Q3 2022)
| Q4 2017 | 19 | 34 | 19 | 10 | 7 |
|---|---|---|---|---|---|
| Q1 2018 | 11 | 32 | 19 | 13 | 11 |
| Q2 2018 | 20 | 39 | 17 | 13 | 4 |
| Q3 2018 | 36 | 43 | 27 | 10 | 3 |
| Q4 2018 | 24 | 57 | 34 | 11 | 5 |
| Q1 2019 | 38 | 48 | 46 | 14 | 9 |
| Q2 2019 | 24 | 57 | 47 | 22 | 5 |
| Q3 2019 | 26 | 66 | 39 | 19 | 12 |
| Q4 2019 | 73 | 80 | 45 | 15 | 2 |
| Q1 2020 | 33 | 76 | 72 | 33 | -2 |
| Q2 2020 | 40 | 75 | 62 | 45 | -15 |
| Q3 2020 | 27 | 69 | 66 | 48 | -26 |
| Q4 2020 | 46 | 69 | 64 | 31 | -12 |
| Q1 2021 | 38 | 77 | 56 | 35 | -6 |
| Q2 2021 | 33 | 69 | 66 | 40 | -16 |
| Q3 2021 | 18 | 71 | 55 | 32 | 2 |
| Q4 2021 | 33 | 48 | 45 | 65 | -47 |
| Q1 2022 | 31 | 38 | 48 | 33 | -9 |
| Q2 2022 | 15 | 43 | 43 | 17 | 18 |
| Q3 2022 | 30 | 38 | 41 | 18 | 10 |
Hedge funds changes in Reata Pharmaceuticals stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 258,000 | 0 |
|---|---|---|
| Q1 2018 | 383,000 | 262,000 |
| Q2 2018 | 2,051,000 | 1,017,000 |
| Q3 2018 | 11,565,000 | 6,865,000 |
| Q4 2018 | 3,327,000 | 3,859,000 |
| Q1 2019 | 12,209,000 | 9,372,000 |
| Q2 2019 | 12,614,000 | 31,704,000 |
| Q3 2019 | 21,333,000 | 54,664,000 |
| Q4 2019 | 156,563,000 | 38,757,000 |
| Q1 2020 | 128,597,000 | 56,645,000 |
| Q2 2020 | 71,147,000 | 51,809,000 |
| Q3 2020 | 38,559,000 | 32,968,000 |
| Q4 2020 | 17,819,000 | 44,540,000 |
| Q1 2021 | 28,725,000 | 43,811,000 |
| Q2 2021 | 30,400,000 | 54,704,000 |
| Q3 2021 | 39,323,000 | 94,663,000 |
| Q4 2021 | 18,741,000 | 13,554,000 |
| Q1 2022 | 21,326,000 | 70,116,000 |
| Q2 2022 | 12,930,000 | 8,041,000 |
| Q3 2022 | 36,842,000 | 24,989,000 |